High-throughput screening of fda-approved drug library reveals ixazomib is a broad-spectrum antiviral agent against arboviruses

HIGHLIGHTS

• who: Cuiling Ding et al. from the Four-week-old female C BL/, mice were used for the in vivo evaluation of the anti-CHIKV activity of the compoundsAll of the procedures that involved animals were reviewed and approved by the Institutional Committee for Animal Care and Biosafety of Navy Medical University. All of the experiments complied with the relevant ethical regulations. All of the mouse infection studies were performed in a laboratory with an animal biosafety level of, . For the animal experiments, the C BL/, mice were randomly distributed into , groups. Each group consisted of nine . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.